- Home
- LNKB vs TKNO Comparison
LNKB vs TKNO Comparison
Compare LNKB & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNKB
- TKNO
- Stock Information
- Founded
- LNKB 2018
- TKNO 1996
- Country
- LNKB United States
- TKNO United States
- Employees
- LNKB N/A
- TKNO N/A
- Industry
- LNKB
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- LNKB
- TKNO Health Care
- Exchange
- LNKB Nasdaq
- TKNO Nasdaq
- Market Cap
- LNKB 236.7M
- TKNO 244.7M
- IPO Year
- LNKB N/A
- TKNO 2021
- Fundamental
- Price
- LNKB $6.25
- TKNO $5.06
- Analyst Decision
- LNKB Hold
- TKNO Buy
- Analyst Count
- LNKB 1
- TKNO 2
- Target Price
- LNKB $7.50
- TKNO $5.00
- AVG Volume (30 Days)
- LNKB 45.7K
- TKNO 122.0K
- Earning Date
- LNKB 10-25-2024
- TKNO 11-07-2024
- Dividend Yield
- LNKB 4.79%
- TKNO N/A
- EPS Growth
- LNKB N/A
- TKNO N/A
- EPS
- LNKB N/A
- TKNO N/A
- Revenue
- LNKB $68,142,000.00
- TKNO $34,940,000.00
- Revenue This Year
- LNKB N/A
- TKNO $3.22
- Revenue Next Year
- LNKB $4.03
- TKNO $14.88
- P/E Ratio
- LNKB N/A
- TKNO N/A
- Revenue Growth
- LNKB 101.22
- TKNO N/A
- 52 Week Low
- LNKB $5.86
- TKNO $1.16
- 52 Week High
- LNKB $8.29
- TKNO $5.46
- Technical
- Relative Strength Index (RSI)
- LNKB 45.31
- TKNO 57.83
- Support Level
- LNKB $6.17
- TKNO $4.68
- Resistance Level
- LNKB $6.46
- TKNO $5.21
- Average True Range (ATR)
- LNKB 0.15
- TKNO 0.37
- MACD
- LNKB -0.01
- TKNO 0.00
- Stochastic Oscillator
- LNKB 13.79
- TKNO 75.51
About LNKB LINKBANCORP Inc.
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.